Clinical Care Options

User Name

Password

Remember Me

Register Forgot Password

Search Site


	CCO Hepatitis Home Featured Content Update on Resistance to HBV and HCV Therapy 2008 Independent Conference Report on Hepatitis B and C Virus Resistance to Antiviral Therapies.		CCO HIV Home Featured Content Strategies to Address Cardiovascular Risk in HIV Question and answer modules on the management of cardiovascular risks in HIV disease.		CCO Oncology Home Featured Content Advances in Metastatic Colorectal Cancer Watch 4 presentations from expert faculty members highlighting advances in mCRC management.


	Now Available from Clinical Care Options Audio Expert Highlights Listen to Audio Expert Highlights From the 2008 EASL Meeting Expert Recap Update on the Management of Treatment Experienced Patients CCO Bookstore Free Monograph: Diagnosis and Treatment of Cutaneous T-Cell Lymphoma Clinical Management Series The Role of Integrase Inhibitors in HIV Management Downloadable Slides Early Breast Cancer: Endocrine Therapy Expert Analysis Hepatitis and Opportunistic Coinfections CCO Independent Conference Coverage 2008 EASL Meeting in Milan Interactive Case Challenge Clinical Management of a 69-Year-Old Man With Intermediate-1-Risk Myelodysplastic Syndrome Interactive Decision Support Tool New Data Update: Drug-Drug Interactions in HIV-Infected Patients				CCO Live Meetings Hepatitis 6th Annual Clinical Care Options Hepatitis Symposium HBV Election 2008 Meet the Clinical Candidates HIV New Insights Into the Use of PIs Across the Treatment Spectrum Integrating New Antiretroviral Agents Into Therapeutic Strategies for Treatment-Experienced Patients Oncology 7th International Symposium on Translational Research in Oncology Clinical Controversies in the Treatment of Anemia: Appropriate Use of ESAs in a Time of Change Translating Science Into Clinical Practice: Recent Lessons in EGFR Inhibition, Multitargeted TKIs, and the Tumor Microenvironment Attacking the Signal at the Switch: Unraveling the Mysteries of mTOR Inhibition in Multiple Tumor Types Advances in Lymphoproliferative Disease: From Molecular Pathogenesis to Multitargeted Treatment